13.10
price down icon3.03%   -0.41
after-market アフターアワーズ: 12.85 -0.25 -1.91%
loading

Stoke Therapeutics Inc (STOK) 最新ニュース

pulisher
Jul 25, 2025

Stoke Therapeutics Inc. Stock Analysis and ForecastFree High-Return Strategy Alerts - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Stoke Therapeutics Inc. a good long term investmentSuperior return velocity - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Stoke Therapeutics Inc. stockExtraordinary market timing - Autocar Professional

Jul 25, 2025
pulisher
Jul 23, 2025

Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Stoke Therapeutics Bets Big On Rare Disease Therapies - Finimize

Jul 23, 2025
pulisher
Jul 23, 2025

Stoke Therapeutics Soars 17.02% on Market Optimism - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Stoke Therapeutics Inc. stock priceRobust investment performance - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Why Stoke Therapeutics Inc. stock attracts strong analyst attentionProven Return Strategy Execution - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-22 15:57:09 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-22 13:02:52 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Jefferies Financial Group Begins Coverage on Stoke Therapeutics (NASDAQ:STOK) - Defense World

Jul 20, 2025
pulisher
Jul 20, 2025

How to Take Advantage of moves in (STOK) - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 19, 2025

Is Stoke Therapeutics, Inc.'s (NASDAQ:STOK) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - 富途牛牛

Jul 19, 2025
pulisher
Jul 19, 2025

Stoke Therapeutics, Inc.'s (NASDAQ:STOK) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - simplywall.st

Jul 19, 2025
pulisher
Jul 19, 2025

Stoke Therapeutics (STOK): A High-Conviction Buy with Disease-Modifying Potential in Dravet Syndrome - AInvest

Jul 19, 2025
pulisher
Jul 18, 2025

Jefferies Recommends Stoke Therapeutics (STOK) with a Buy Rating - GuruFocus

Jul 18, 2025
pulisher
Jul 18, 2025

Jefferies initiates Stoke Therapeutics stock with Buy rating on epilepsy drug potential - Investing.com Canada

Jul 18, 2025
pulisher
Jul 18, 2025

Published on: 2025-07-18 11:35:29 - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 17, 2025

Stoke Therapeutics’ EMPEROR Study: A New Hope for Dravet Syndrome - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 16, 2025 - BioSpace

Jul 17, 2025
pulisher
Jul 16, 2025

Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Stoke Therapeutics (STOK) - The Globe and Mail

Jul 16, 2025
pulisher
Jul 15, 2025

How Stoke Therapeutics Inc. stock performs during market volatilityProven Trading Plan - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Stoke Therapeutics Inc. stock price move sharplyDaily Price Surge List - Newser

Jul 15, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):